| Revenue growth | 35.3% YoY for Q1 FY27 |
|---|---|
| Margins | EBITDA margin at 20.1% vs 22.7% YoY |
| Demand visibility | Strong IP/OP volumes up 26.6% and 28.5% YoY |
| Management confidence | High; citing 'consistent performer over 2 decades' |
Growth
Revenue grew 35.3% YoY to ₹11,795 Mn. EBITDA increased 20.1% YoY to ₹2,398 Mn, though EBITDA margins contracted to 20.1% due to new unit ramp-ups.
Outlook
Targeting 9600+ bed capacity; added 1300+ beds via Greenfield and O&M. Focus on ramping up Maharashtra and Kerala units.
Risks
PAT fell 56% YoY to ₹374 Mn, impacted by statutory labor code changes and losses from new facility operationalization.
Last quarter's promises, checked
Delivered
- Guided Thane EBITDA break-even by March exit → delivered Neutral (= BEAT)
- Guided 75k ARPOB for Bangalore → delivered ~85k (= BEAT)
- Guided 60% Maharashtra occupancy base → delivered 60.5% (= BEAT)
Partly delivered
- Guided 35-40% Bangalore occupancy by year-end → delivered 20-odd% currently (= PARTIAL)
Missed
- Guided Maharashtra losses narrowing to 6-7cr → delivered higher impact from new units (= MISS)
Investor Presentation filed with BSE, NSE: KIMS. Summary written with AI assistance from the document.
Krishna Institute of Medical Sciences Ltd: key numbers
- Share price
- ₹693.40
- Market cap
- ₹29,123 Cr
- Revenue (annual)
- ₹3,905 Cr
- Net profit (annual)
- ₹241.4 Cr
- P/E (TTM)
- 142.6×Sector 53.1×
- Promoter holding
- 32.50%-1.61% QoQ
- FII holding
- 14.75%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Krishna Institute of Medical Sciences Ltd
All →Krishna Institute of Medical Sciences Share Pledge
Promoters pledged 2,80,08,979 equity shares (6.66%) to Catalyst Trusteeship as debenture trustee. The pledge secures existing debenture obligations with no new capital involved.
Krishna Institute of Medical Sciences Capacity Expansion
Krishna Institute of Medical Sciences Ltd entered an Operations and Management Agreement with Sarvottam Health Care Pvt Ltd for 5+5 years to manage their operations.
- Execution
- 5 years with an extension for a further period of 5 years
Krishna Institute of Medical Sciences Annual General Meeting
KIMS Hospitals held its 24th Annual General Meeting on August 27, 2026. The meeting discussed financial statements and various ordinary and special business items.
Krishna Institute of Medical Sciences Price Movement Clarification
KIMS has clarified that the news report claiming a $52 million acquisition of Renova Hospitals is false. The company confirms no such discussions or agreements exist.
Krishna Institute of Medical Sciences Partnership
KIMS entered into an Operations and Management Agreement and Call Option Agreement with Aurevia Hospitals to manage Arete Hospitals for an initial five-year term.
- Execution
- Initial term of 5 years, extendable for 5 years
Krishna Institute of Medical Sciences Business Update
KIMS has entered into an Operations and Management Agreement to manage Arete Hospitals, Hyderabad, for an initial 5-year term. It also secured an acquisition call option.
- Execution
- 5 years